IL1R1 and primary myelofibrosis: Here, we show that IL-1 signaling contributes to clonal expansion and progression of bone marrow fibrosis, and blocking of IL-1R1 with anti-IL-1R1 antibodies reduces the MPN disease burden and ameliorates bone marrow fibrosis in a Jak2V617F mouse model of MPN.